Kestra Medical Technologies
(NASDAQ) KMTS
Kestra Medical Technologies Financials at a Glance
Market Cap
$1.17B
Revenue (TTM)
$83.72M
Net Income (TTM)
$144.83M
EPS (TTM)
$-2.81
P/E Ratio
-7.13
Dividend
$0.00
Beta (Volatility)
1.40 (Average)
Dividend
$0.00
Beta (Volatility)
1.40 (Average)
Price
$19.91
Volume
14,904
Open
$19.27
Price
$19.91
Volume
14,904
Open
$19.27
Previous Close
$19.91
Daily Range
$19.27 - $20.36
52-Week Range
$13.25 - $30.00
Dividend
$0.00
Beta (Volatility)
1.40 (Average)
Price
$19.91
Volume
14,904
Open
$19.27
Previous Close
$19.91
Daily Range
$19.27 - $20.36
52-Week Range
$13.25 - $30.00
KMTS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Kestra Medical Technologies
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
330
CEO
Brian Webster, MBA
Website
www.kestramedical.com/aboutHeadquarters
Kirkland, WA 98033, US
KMTS Financials
Key Financial Metrics (TTM)
Gross Margin
49%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
-98%
Return on Capital
-43%
Return on Assets
-38%
Earnings Yield
-14.03%
Dividend Yield
0.00%
Payout Ratio
-0.02%
Stock Overview
Market Cap
$1.17B
Shares Outstanding
58.37M
Volume
14.90K
Short Interest
0.00%
Avg. Volume
353.39K
Financials (TTM)
Gross Profit
$24.21M
Operating Income
$106.38M
EBITDA
$97.98M
Operating Cash Flow
$77.61M
Capital Expenditure
$23.59M
Free Cash Flow
$101.20M
Cash & ST Invst.
$237.59M
Total Debt
$44.31M
Kestra Medical Technologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$24.55M
+62.7%
Gross Profit
$12.91M
+97.1%
Gross Margin
52.57%
N/A
Market Cap
$1.17B
N/A
Market Cap/Employee
$3.90M
N/A
Employees
300
N/A
Net Income
$34.17M
-58.8%
EBITDA
$30.26M
-67.5%
Quarterly Fundamentals
Net Cash
$287.04M
+3608.0%
Accounts Receivable
$12.71M
+60.3%
Inventory
$0.00
-100.0%
Long Term Debt
$4.28M
-90.8%
Short Term Debt
$10.00K
N/A
Return on Assets
-38.18%
N/A
Return on Invested Capital
-42.69%
N/A
Free Cash Flow
$28.16M
-25.5%
Operating Cash Flow
$18.37M
+0.1%